Abstract
Objective
Complete resection of malignant gliomas is often challenging. Our previous study indicated that intraoperative contrast-enhanced ultrasound (ICEUS) could aid in the detection of residual tumor remnants and the total removal of brain lesions. This study aimed to investigate the survival rates of patients undergoing resection with or without the use of ICEUS and to assess the impact of ICEUS on the prognosis of patients with malignant glioma.
Methods
A total of 64 patients diagnosed with malignant glioma (WHO grade HI and IV) who underwent surgery between 2012 and 2018 were included. Among them, 29 patients received ICEUS. The effects of ICEUS on overall survival (OS) and progression-free survival (PFS) of patients were evaluated. A quantitative analysis was performed to compare ICEUS parameters between gliomas and the surrounding tissues.
Results
The ICEUS group showed better survival rates both in OS and PFS than the control group. The univariate analysis revealed that age, pathology and ICEUS were significant prognostic factors for PFS, with only age being a significant prognostic factor for OS. In multivariate analysis, age and ICEUS were significant prognostic factors for both OS and PFS. The quantitative analysis showed that the intensity and transit time of microbubbles reaching the tumors were significantly different from those of microbubbles reaching the surrounding tissue.
Conclusion
ICEUS facilitates the identification of residual tumors. Age and ICEUS are prognostic factors for malignant glioma surgery, and use of ICEUS offers a better prognosis for patients with malignant glioma.
Similar content being viewed by others
References
Weller M, Wick W, Aldape K, et al. Glioma. Nat Rev Dis Primers, 2015,1:15017
Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med, 2008,359(5):492–507
Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol, 2007,114(2):97–109
Galbraith K, Snuderl M. Molecular Pathology of Gliomas. Surg Pathol Clin, 2021,14(3):379–386
Schiff D, Van den Bent M, Vogelbaum MA, et al. Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensus. Neuro Oncol, 2019,21(7):837–853
Colman H. Adult Gliomas. Continuum (Minneap Minn), 2020,26(6):1452–1475
Unsgaard G, Gronningsaeter A, Ommedal S, et al. Brain operations guided by real-time two-dimensional ultrasound: new possibilities as a result of improved image quality. Neurosurgery, 2002,51(2):402–411; discussion 411–412
Petridis AK, Anokhin M, Vavruska J, et al. The value of intraoperative sonography in low grade glioma surgery. Clin Neurol Neurosurg, 2015,131:64–68
Le Roux PD, Berger MS, Wang K, et al. Low grade gliomas: comparison of intraoperative ultrasound characteristics with preoperative imaging studies. J Neurooncol, 1992,13(2):189–198
LeRoux PD, Winter TC, Berger MS, et al. A comparison between preoperative magnetic resonance and intraoperative ultrasound tumor volumes and margins. J Clin Ultrasound, 1994,22(1):29–36
Tao AY, Chen X, Zhang LY, et al. Application of Intraoperative Contrast-Enhanced Ultrasound in the Resection of Brain Tumors. Curr Med Sci, 2022,42(1):169–176
Prada F, Bene MD, Fornaro R, et al. Identification of residual tumor with intraoperative contrast-enhanced ultrasound during glioblastoma resection. Neurosurg Focus, 2016,40(3):E7
Wang J, Yang Y, Liu X, et al. Intraoperative contrast-enhanced ultrasound for cerebral glioma resection and the relationship between microvascular perfusion and microvessel density. Clin Neurol Neurosurg, 2019,186:105512
Prada F, Mattei L, Del Bene M, et al. Intraoperative cerebral glioma characterization with contrast enhanced ultrasound. Biomed Res Int, 2014:2014:484261
Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med, 2005,352(10):987–996
Comba A, Faisal SM, Varela ML, et al. Uncovering Spatiotemporal Heterogeneity of High-Grade Gliomas: From Disease Biology to Therapeutic Implications. Front Oncol, 2021,11:703764
Hong JB, Roh TH, Kang SG, et al. Survival, Prognostic Factors, and Volumetric Analysis of Extent of Resection for Anaplastic Gliomas. Cancer Res Treat, 2020,52(4):1041–1049
Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol, 2021,23(8):1231–1251
Gritsch S, Batchelor TT, Gonzalez Castro LN. Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system. Cancer, 2022,128(1):47–58
Li YM, Suki D, Hess K, et al. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection? J Neurosurg, 2016,124(4):977–88
Harrer JU, Hornen S, Oertel MF, et al. Comparison of perfusion harmonic imaging and perfusion mr imaging for the assessment of microvascular characteristics in brain tumors. Ultraschall Med, 2008,29(1):45–52
Prada F, Perin A, Martegani A, et al. Intraoperative contrast-enhanced ultrasound for brain tumor surgery. Neurosurgery, 2014,74(5):542–552
Plate KH, Risau W. Angiogenesis in malignant gliomas. Glia, 1995,15(3):339–347
Ahir BK, Engelhard HH, Lakka SS. Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma. Mol Neurobiol, 2020,57(5):2461–2478
Sastry R, Bi WL, Pieper S, et al. Applications of Ultrasound in the Resection of Brain Tumors. J Neuroimaging, 2017,27(1):5–15
Shang Y, Xie X, Luo Y, et al. Safety findings after intravenous administration of sulfur hexafluoride microbubbles to 463,434 examinations at 24 centers. Eur Radiol, 2023,33(2):988–995
Schaible J, Stroszczynski C, Beyer LP, et al. Quantitative perfusion analysis of hepatocellular carcinoma using dynamic contrast enhanced ultrasound (CEUS) to determine tumor microvascularization. Clin Hemorheol Microcirc, 2019,73(1):95–104
Cheng LG, He W, Zhang HX, et al. Intraoperative Contrast Enhanced Ultrasound Evaluates the Grade of Glioma. Biomed Res Int, 2016:2016:643862
Lassau N, Chami L, Chebil M, et al. Dynamic contrast-enhanced ultrasonography (DCE-US) and anti-angiogenic treatments. Discov Med, 2011,11(56):18–24
Hervey-Jumper SL, Berger MS. Maximizing safe resection of low- and high-grade glioma. J Neurooncol, 2016,130(2):269–282
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare that they have no conflict of interest.
Additional information
This research was funded by grants from the Natural Science Foundation of Hubei Province, China (No. 2022CFB307) and the Foundation of Tongji Hospital (No. 2020JZKT292).
Rights and permissions
About this article
Cite this article
Chen, X., Peng, Yn., Cheng, Fl. et al. Survival Analysis of Patients Undergoing Intraoperative Contrast-enhanced Ultrasound in the Surgical Treatment of Malignant Glioma. CURR MED SCI 44, 399–405 (2024). https://doi.org/10.1007/s11596-024-2840-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-024-2840-z